位置:成果数据库 > 期刊 > 期刊详情页
siRNA沉默TLR4表达对人肺腺癌A549细胞增殖和侵袭的影响
  • ISSN号:1007-385X
  • 期刊名称:中国肿瘤生物治疗杂志
  • 时间:2014.12.20
  • 页码:635-639
  • 分类:R734.1[医药卫生—肿瘤;医药卫生—临床医学] R730.54[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]辽宁中医药大学教学实验中心生物技术实验室,辽宁沈阳,110847, [2]辽宁中医药大学基础医学院生物化学教研室,辽宁沈阳110847
  • 相关基金:国家自然科学基金资助项目(No.81202789); 辽宁省教育厅高等学校科研资助项目(No.2009A500); 辽宁省博士启动基金资助项目(No.20111134)
  • 相关项目:培土生金法通过TLR4信号通路干预LPS诱导的肺癌增殖研究
中文摘要:

目的:探讨靶向TLR4基因的小干扰RNA(small interference RNA,siRNA)对人肺腺癌A549细胞增殖和侵袭的影响。方法:设计并合成针对TLR4基因的3条siRNA(siRNA722、siRNA1673和siRNA2560)及1条与TLR4基因无同源性的阴性对照siRNA,采用Real-time PCR和Western blotting方法测定干扰后A549细胞中TLR4 mRNA及蛋白的表达水平,筛选出有效抑制靶基因表达的siRNA并确定最佳转染条件。TLR4特异性siRNA(TLR4-siRNA)转染A549细胞后,采用CCK-8法和Transwell小室法分别检测沉默TLR4对A549细胞增殖和侵袭能力的影响。结果:与阴性对照相比,siRNA1673在转染48 h后对TLR4 mRNA和蛋白表达的抑制最为明显[(0.45±0.03)vs(0.83±0.02),(0.23±0.06)vs(0.98±0.09);均P〈0.01]。TLR4-siRNA转染72 h后A549细胞增殖活性显著下降[(0.77±0.01)vs(0.98±0.11)、(0.93±0.04),P〈0.01];转染48 h后,TLR4-siRNA组A549细胞的侵袭细胞数明显少于阴性对照组[(23.60±2.88)vs(59.80±5.54)个,P〈0.01]。结论:TLR4-siRNA能够沉默A549细胞中TLR4基因表达,抑制A549细胞的增殖和侵袭能力,TLR4可能成为肺癌基因治疗的候选靶点。

英文摘要:

Objective:To investigate the effects of small interference RNA (siRNA)-mediated TLR4 silencing on pro- liferation and invasion of human lung adenocarcinoma A549 cells. Methods : Three TLR4-specific siRNAs ( siRNA722, siRNA1673 and siRNA2560) and one negative control siRNA were designed and chemically synthesized. One siRNA that could most effectively silence the TLR4 gene in A549 cells was chosen from the three test siRNAs based on their capacity of lowering TLR4 mRNA and protein levels revealed by real-time PCR and Western blotting analysis respectively. A549 cells were transfected with this most effective siRNA and the control siRNA respectively. Proliferation and invasion capaci- ty of the transfectants were assessed by CCK-8 assay and Transwell assay, respectively. Results: TLR4-siRNA1673 was the most effective siRNA which could significantly inhibit the expression of TLR4 at both mRNA (0.45 ± 0.03 vs 0. 83± 0.02, P 〈 0.01 ) and protein (0.23 ±0.06 vs O. 98 ± 0.09) levels at 48 h after transfection into A549 cells as compared with negative control siRNA. The proliferation of the TLR4-siRNA1673-transfected A549 cells was significantly inhibited compared with the NS-siRNA-transfected A549 ceils (P 〈 0.05 ). Similarly, the invasion capacity was significantly lower in the TLR4-siRNA1673-transfected A549 cells than in the NS-siRNA-transfected cells (23.60 ±2.88 vs 59.80±5.54,P 〈 0. 01 ). Conclusion: Sequence-specific and invasion ability of human lung carcinoma a putative therapeutic target for lung cancer. siRNA may effectively silence TLR4 expression and inhibit the proliferation cells in vitro. This preliminary observation suggests that TLR4 may serve as

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国肿瘤生物治疗杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中国免疫学会 中国抗癌协会
  • 主编:曹雪涛
  • 地址:上海市杨浦区翔殷路800号
  • 邮编:200433
  • 邮箱:cjcb@biother.com
  • 电话:021-55620605-22 81871002-22
  • 国际标准刊号:ISSN:1007-385X
  • 国内统一刊号:ISSN:31-1725/R
  • 邮发代号:4-576
  • 获奖情况:
  • 《中国学术期刊(光盘版)检索与评价数据规范》第...
  • 国内外数据库收录:
  • 俄罗斯文摘杂志,美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,中国中国科技核心期刊,中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),瑞典开放获取期刊指南
  • 被引量:6458